{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:12:36Z","timestamp":1793747556517,"version":"4.6.1"},"reference-count":50,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>Defects in the apoptotic machinery and augmented survival signals contribute to drug resistance in glioblastoma (GBM). Moreover, another complexity related to GBM treatment is the concept that GBM development and recurrence may arise from the expression of GBM stem cells (GSCs). Therefore, the use of a multifaceted approach or multitargeted agents that affect specific tumor cell characteristics will likely be necessary to successfully eradicate GBM. The objective of this study was to investigate the usefulness of sulforaphane (SFN)\u2014a constituent of cruciferous vegetables with a multitargeted effect\u2014as a therapeutic agent for GBM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>The inhibitory effects of SFN on established cell lines, early primary cultures, CD133-positive GSCs, GSC-derived spheroids, and GBM xenografts were evaluated using various methods, including GSC isolation and the sphere-forming assay, analysis of reactive oxygen species (ROS) and apoptosis, cell growth inhibition assay, comet assays for assessing SFN-triggered DNA damage, confocal microscopy, Western blot analysis, and the determination of in vivo efficacy as assessed in human GBM xenograft models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>SFN triggered the significant inhibition of cell survival and induced apoptotic cell death, which was associated with caspase 3 and caspase 7 activation. Moreover, SFN triggered the formation of mitochondrial ROS, and SFN-triggered cell death was ROS dependent. Comet assays revealed that SFN increased single- and double-strand DNA breaks in GBM. Compared with the vehicle control cells, a significantly higher amount of \u03b3-H2AX foci correlated with an increase in DNA double-strand breaks in the SFN-treated samples. Furthermore, SFN robustly inhibited the growth of GBM cell\u2013induced cell death in established cell cultures and early-passage primary cultures and, most importantly, was effective in eliminating GSCs, which play a major role in drug resistance and disease recurrence. In vivo studies revealed that SFN administration at 100 mg\/kg for 5-day cycles repeated for 3 weeks significantly decreased the growth of ectopic xenografts that were established from the early passage of primary cultures of GBM10.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>These results suggest that SFN is a potent anti-GBM agent that targets several apoptosis and cell survival pathways and further preclinical and clinical studies may prove that SFN alone or in combination with other therapies may be potentially useful for GBM therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3171\/2016.8.jns161197","type":"journal-article","created":{"date-parts":[[2017,1,6]],"date-time":"2017-01-06T10:01:14Z","timestamp":1483696874000},"page":"1219-1230","source":"Crossref","is-referenced-by-count":41,"title":["Sulforaphane suppresses the growth of glioblastoma cells, glioblastoma stem cell\u2013like spheroids, and tumor xenografts through multiple cell signaling pathways"],"prefix":"10.3171","volume":"127","author":[{"given":"Khadijeh","family":"Bijangi-Vishehsaraei","sequence":"first","affiliation":[{"name":"Indiana University Simon Cancer Center;"},{"name":"Departments of Pharmacology and Toxicology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Reza Saadatzadeh","sequence":"additional","affiliation":[{"name":"Indiana University Simon Cancer Center;"},{"name":"Neurosurgery, Indiana University School of Medicine and Goodman Campbell Brain and Spine;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Wang","sequence":"additional","affiliation":[{"name":"Indiana University Simon Cancer Center;"},{"name":"Herman B. Wells Center for Pediatric Research;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angie","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Indiana University Simon Cancer Center;"},{"name":"Departments of Pharmacology and Toxicology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata M.","family":"Kamocka","sequence":"additional","affiliation":[{"name":"Indiana Center for Biological Microscopy, Indiana University School of Medicine, Indianapolis;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Cai","sequence":"additional","affiliation":[{"name":"Indiana University Simon Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron A.","family":"Cohen-Gadol","sequence":"additional","affiliation":[{"name":"Neurosurgery, Indiana University School of Medicine and Goodman Campbell Brain and Spine;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey L.","family":"Halum","sequence":"additional","affiliation":[{"name":"Purdue University and the Voice Clinic of Indiana, Lafayette, Indiana; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jann N.","family":"Sarkaria","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen E.","family":"Pollok","sequence":"additional","affiliation":[{"name":"Indiana University Simon Cancer Center;"},{"name":"Departments of Pharmacology and Toxicology and"},{"name":"Herman B. Wells Center for Pediatric Research;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad R.","family":"Safa","sequence":"additional","affiliation":[{"name":"Indiana University Simon Cancer Center;"},{"name":"Departments of Pharmacology and Toxicology and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"key":"b1-jns161197","series-title":"Mol Pharmacol","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1124\/mol.111.072363","article-title":"Sulforaphane suppresses polycomb group protein level via a proteasome-dependent mechanism in skin cancer cells","volume":"80","author":"Balasubramanian S,","year":"2011","unstructured":"Balasubramanian S, Chew YC, Eckert RL: Sulforaphane suppresses polycomb group protein level via a proteasome-dependent mechanism in skin cancer cells. Mol Pharmacol 80:870\u2013878, 201110.1124\/mol.111.072363"},{"key":"b2-jns161197","series-title":"Mol Cell Biochem","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s11010-010-0477-7","article-title":"4-(4-Chloro-2-methylphenoxy)-N-hydroxybutanamide (CMH) targets mRNA of the c-FLIP variants and induces apoptosis in MCF-7 human breast cancer cells","volume":"342","author":"Bijangi-Vishehsaraei K,","year":"2010","unstructured":"Bijangi-Vishehsaraei K, Saadatzadeh MR, Huang S, Murphy MP, Safa AR: 4-(4-Chloro-2-methylphenoxy)-N-hydroxybutanamide (CMH) targets mRNA of the c-FLIP variants and induces apoptosis in MCF-7 human breast cancer cells. Mol Cell Biochem 342:133\u2013142, 20102044601910.1007\/s11010-010-0477-7"},{"key":"b3-jns161197","series-title":"Stem Cells","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1002\/stem.1317","article-title":"CD133 is essential for glioblastoma stem cell maintenance","volume":"31","author":"Brescia P,","year":"2013","unstructured":"Brescia P, Ortensi B, Fornasari L, Levi D, Broggi G, Pelicci G: CD133 is essential for glioblastoma stem cell maintenance. Stem Cells 31:857\u2013869, 20132330758610.1002\/stem.1317"},{"key":"b4-jns161197","series-title":"Biochim Biophys Acta","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.bbadis.2011.11.002","article-title":"Cellular stress responses, hormetic phytochemicals and vitagenes in aging and longevity","volume":"1822","author":"Calabrese V,","year":"2012","unstructured":"Calabrese V, Cornelius C, Dinkova-Kostova AT, Iavicoli I, Di Paola R, Koverech A, : Cellular stress responses, hormetic phytochemicals and vitagenes in aging and longevity. Biochim Biophys Acta 1822:753\u2013783, 20122210820410.1016\/j.bbadis.2011.11.002"},{"key":"b5-jns161197","series-title":"Oral Oncol","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.oraloncology.2008.07.003","article-title":"Sulforaphane enhances caspase-dependent apoptosis through inhibition of cyclooxygenase-2 expression in human oral squamous carcinoma cells and nude mouse xenograft model","volume":"45","author":"Cho NP,","year":"2009","unstructured":"Cho NP, Han HS, Leem DH, Choi IS, Jung JY, Kim HJ, : Sulforaphane enhances caspase-dependent apoptosis through inhibition of cyclooxygenase-2 expression in human oral squamous carcinoma cells and nude mouse xenograft model. Oral Oncol 45:654\u2013660, 20091880504510.1016\/j.oraloncology.2008.07.003"},{"key":"b6-jns161197","series-title":"Nutr Cancer","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1080\/01635581.2014.864777","article-title":"Sulforaphane induces DNA damage and mitotic abnormalities in human osteosarcoma MG-63 cells: correlation with cell cycle arrest and apoptosis","volume":"66","author":"Ferreira de Oliveira JM,","year":"2014","unstructured":"Ferreira de Oliveira JM, Rem\u00e9dios C, Oliveira H, Pinto P, Pinho F, Pinho S, : Sulforaphane induces DNA damage and mitotic abnormalities in human osteosarcoma MG-63 cells: correlation with cell cycle arrest and apoptosis. Nutr Cancer 66:325\u2013334, 20142440529710.1080\/01635581.2014.864777"},{"key":"b7-jns161197","series-title":"Anticancer Drugs","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/00001813-199802000-00005","article-title":"Selective cytostatic and cytotoxic effects of glucosinolates hydrolysis products on human colon cancer cells in vitro","volume":"9","author":"Gamet-Payrastre L,","year":"1998","unstructured":"Gamet-Payrastre L, Lumeau S, Gasc N, Cassar G, Rollin P, Tulliez J: Selective cytostatic and cytotoxic effects of glucosinolates hydrolysis products on human colon cancer cells in vitro. Anticancer Drugs 9:141\u2013148, 1998951050010.1097\/00001813-199802000-00005"},{"key":"b8-jns161197","series-title":"Clin Cancer Res","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1158\/1078-0432.CCR-03-0384","article-title":"Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide","volume":"10","author":"Hegi ME,","year":"2004","unstructured":"Hegi ME, Diserens AC, Godard S, Dietrich PY, Regli L, Ostermann S, : Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide. Clin Cancer Res 10:1871\u20131874, 20041504170010.1158\/1078-0432.CCR-03-0384"},{"key":"b9-jns161197","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1056\/NEJMoa043331","article-title":"MGMT gene silencing and benefit from temozolomide in glioblastoma","volume":"352","author":"Hegi ME,","year":"2005","unstructured":"Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, : MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352:997\u20131003, 20051575801010.1056\/NEJMoa043331"},{"key":"b10-jns161197","series-title":"J Immunol","doi-asserted-by":"publisher","first-page":"680","DOI":"10.4049\/jimmunol.181.1.680","article-title":"The transcription factor Nrf2 is a therapeutic target against brain inflammation","volume":"181","author":"Innamorato NG,","year":"2008","unstructured":"Innamorato NG, Rojo AI, Garc\u00eda-Yag\u00fce AJ, Yamamoto M, de Ceballos ML, Cuadrado A: The transcription factor Nrf2 is a therapeutic target against brain inflammation. J Immunol 181:680\u2013689, 20081856643510.4049\/jimmunol.181.1.680"},{"key":"b11-jns161197","series-title":"Carcinogenesis","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1093\/carcin\/bgu243","article-title":"Glioblastoma stem-like cells: at the root of tumor recurrence and a therapeutic target","volume":"36","author":"Jackson M,","year":"2015","unstructured":"Jackson M, Hassiotou F, Nowak A: Glioblastoma stem-like cells: at the root of tumor recurrence and a therapeutic target. Carcinogenesis 36:177\u2013185, 201510.1093\/carcin\/bgu243"},{"key":"b12-jns161197","series-title":"Carcinogenesis","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1093\/carcin\/bgg192","article-title":"Sulforaphane: a naturally occurring mammary carcinoma mitotic inhibitor, which disrupts tubulin polymerization","volume":"25","author":"Jackson SJ,","year":"2004","unstructured":"Jackson SJ, Singletary KW: Sulforaphane: a naturally occurring mammary carcinoma mitotic inhibitor, which disrupts tubulin polymerization. Carcinogenesis 25:219\u2013227, 20041457815710.1093\/carcin\/bgg192"},{"key":"b13-jns161197","series-title":"Biochim Biophys Acta","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/j.bbapap.2011.05.015","article-title":"Sulforaphane induces apoptosis in human hepatic cancer cells through inhibition of 6-phosphofructo-2-kinase\/fructose-2,6-biphosphatase4, mediated by hypoxia inducible factor-1-dependent pathway","volume":"1814","author":"Jeon YK,","year":"2011","unstructured":"Jeon YK, Yoo DR, Jang YH, Jang SY, Nam MJ: Sulforaphane induces apoptosis in human hepatic cancer cells through inhibition of 6-phosphofructo-2-kinase\/fructose-2,6-biphosphatase4, mediated by hypoxia inducible factor-1-dependent pathway. Biochim Biophys Acta 1814:1340\u20131348, 20112164085210.1016\/j.bbapap.2011.05.015"},{"key":"b14-jns161197","series-title":"Carcinogenesis","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1093\/carcin\/bgl251","article-title":"Sulforaphane sensitizes tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis through down-regulation of ERK and Akt in lung adenocarcinoma A549 cells","volume":"28","author":"Jin CY,","year":"2007","unstructured":"Jin CY, Moon DO, Lee JD, Heo MS, Choi YH, Lee CM, : Sulforaphane sensitizes tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis through down-regulation of ERK and Akt in lung adenocarcinoma A549 cells. Carcinogenesis 28:1058\u20131066, 20071718306410.1093\/carcin\/bgl251"},{"key":"b15-jns161197","series-title":"Crit Rev Eukaryot Gene Expr","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1615\/CritRevEukaryotGeneExpr.2015015601","article-title":"Hypoxia is the driving force behind GBM and could be a new tool in GBM treatment","volume":"25","author":"Kalkan R:","year":"2015","unstructured":"Kalkan R: Hypoxia is the driving force behind GBM and could be a new tool in GBM treatment. Crit Rev Eukaryot Gene Expr 25:363\u2013369, 20152655909610.1615\/CritRevEukaryotGeneExpr.2015015601"},{"key":"b16-jns161197","series-title":"Neuro Oncol","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1093\/neuonc\/nos299","article-title":"Wnt\/\u03b2-catenin signaling is a key downstream mediator of MET signaling in glioblastoma stem cells","volume":"15","author":"Kim KH,","year":"2013","unstructured":"Kim KH, Seol HJ, Kim EH, Rheey J, Jin HJ, Lee Y, : Wnt\/\u03b2-catenin signaling is a key downstream mediator of MET signaling in glioblastoma stem cells. Neuro Oncol 15:161\u2013171, 20132325884410.1093\/neuonc\/nos299"},{"key":"b17-jns161197","series-title":"Mol Cancer","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1476-4598-9-135","article-title":"Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeutics","volume":"9","author":"Krakstad C,","year":"2010","unstructured":"Krakstad C, Chekenya M: Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeutics. Mol Cancer 9:135, 20102051549510.1186\/1476-4598-9-135"},{"key":"b18-jns161197","series-title":"In Vivo","first-page":"305","article-title":"Gamma-H2AX - a novel biomarker for DNA double-strand breaks","volume":"22","author":"Kuo LJ,","year":"2008","unstructured":"Kuo LJ, Yang LX: Gamma-H2AX - a novel biomarker for DNA double-strand breaks. In Vivo 22:305\u2013309, 200818610740"},{"key":"b19-jns161197","series-title":"J Neurochem","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/jnc.13272","article-title":"miR-144-3p exerts antitumor effects in glioblastoma by targeting c-Met","volume":"135","author":"Lan F,","year":"2015","unstructured":"Lan F, Yu H, Hu M, Xia T, Yue X: miR-144-3p exerts antitumor effects in glioblastoma by targeting c-Met. J Neurochem 135:274\u2013286, 201510.1111\/jnc.13272"},{"key":"b20-jns161197","series-title":"Cell Stem Cell","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.stem.2011.04.013","article-title":"Deadly teamwork: neural cancer stem cells and the tumor microenvironment","volume":"8","author":"Lathia JD,","year":"2011","unstructured":"Lathia JD, Heddleston JM, Venere M, Rich JN: Deadly teamwork: neural cancer stem cells and the tumor microenvironment. Cell Stem Cell 8:482\u2013485, 20112154932410.1016\/j.stem.2011.04.013"},{"key":"b21-jns161197","series-title":"Oncol Rep","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.3892\/or.2015.4292","article-title":"Isothiocyanates inhibit the invasion and migration of C6 glioma cells by blocking FAK\/JNK-mediated MMP-9 expression","volume":"34","author":"Lee CS,","year":"2015","unstructured":"Lee CS, Cho HJ, Jeong YJ, Shin JM, Park KK, Park YY, : Isothiocyanates inhibit the invasion and migration of C6 glioma cells by blocking FAK\/JNK-mediated MMP-9 expression. Oncol Rep 34:2901\u20132908, 20152639719410.3892\/or.2015.4292"},{"key":"b22-jns161197","series-title":"Cancer Treat Res","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/978-3-642-38007-5_12","article-title":"Sulforaphane as a promising molecule for fighting cancer","volume":"159","author":"Lenzi M,","year":"2014","unstructured":"Lenzi M, Fimognari C, Hrelia P: Sulforaphane as a promising molecule for fighting cancer. Cancer Treat Res 159:207\u2013223, 20142411448210.1007\/978-3-642-38007-5_12"},{"key":"b23-jns161197","series-title":"Future Oncol","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.2217\/fon.13.108","article-title":"Targeting cancer stem cells with sulforaphane, a dietary component from broccoli and broccoli sprouts","volume":"9","author":"Li Y,","year":"2013","unstructured":"Li Y, Zhang T: Targeting cancer stem cells with sulforaphane, a dietary component from broccoli and broccoli sprouts. Future Oncol 9:1097\u20131103, 20132390224210.2217\/fon.13.108"},{"key":"b24-jns161197","series-title":"PLoS One","doi-asserted-by":"publisher","first-page":"e37748","DOI":"10.1371\/journal.pone.0037748","article-title":"Bioactive dietary supplements reactivate ER expression in ER-negative breast cancer cells by active chromatin modifications","volume":"7","author":"Meeran SM,","year":"2012","unstructured":"Meeran SM, Patel SN, Li Y, Shukla S, Tollefsbol TO: Bioactive dietary supplements reactivate ER expression in ER-negative breast cancer cells by active chromatin modifications. PLoS One 7:e37748, 20122266220810.1371\/journal.pone.0037748"},{"key":"b25-jns161197","series-title":"Exp Biol Med (Maywood)","first-page":"227","article-title":"Sulforaphane retards the growth of human PC-3 xenografts and inhibits HDAC activity in human subjects","volume":"232","author":"Myzak MC,","year":"2007","unstructured":"Myzak MC, Tong P, Dashwood WM, Dashwood RH, Ho E: Sulforaphane retards the growth of human PC-3 xenografts and inhibits HDAC activity in human subjects. Exp Biol Med (Maywood) 232:227\u2013234, 2007"},{"key":"b26-jns161197","series-title":"Brain Res","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.brainres.2014.10.062","article-title":"Mitochondrial energy metabolism and apoptosis regulation in glioblastoma","volume":"1595","author":"Nagy A,","year":"2015","unstructured":"Nagy A, Eder K, Selak MA, Kalman B: Mitochondrial energy metabolism and apoptosis regulation in glioblastoma. Brain Res 1595:127\u2013142, 20152545112010.1016\/j.brainres.2014.10.062"},{"key":"b27-jns161197","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"324","DOI":"10.3171\/2014.9.JNS132253","article-title":"Stem cell signature in glioblastoma: therapeutic development for a moving target","volume":"122","author":"Nakano I:","year":"2015","unstructured":"Nakano I: Stem cell signature in glioblastoma: therapeutic development for a moving target. J Neurosurg 122:324\u2013330, 20152539736810.3171\/2014.9.JNS132253"},{"key":"b28-jns161197","series-title":"Free Radic Biol Med","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.freeradbiomed.2013.08.182","article-title":"Modulation of mitochondrial functions by the indirect antioxidant sulforaphane: a seemingly contradictory dual role and an integrative hypothesis","volume":"65","author":"Negrette-Guzm\u00e1n M,","year":"2013","unstructured":"Negrette-Guzm\u00e1n M, Huerta-Yepez S, Tapia E, Pedraza-Chaverri J: Modulation of mitochondrial functions by the indirect antioxidant sulforaphane: a seemingly contradictory dual role and an integrative hypothesis. Free Radic Biol Med 65:1078\u20131089, 201310.1016\/j.freeradbiomed.2013.08.182"},{"key":"b29-jns161197","series-title":"J Biol Chem","doi-asserted-by":"publisher","first-page":"51057","DOI":"10.1074\/jbc.M406543200","article-title":"Taxol induces caspase-10-dependent apoptosis","volume":"279","author":"Park SJ,","year":"2004","unstructured":"Park SJ, Wu CH, Gordon JD, Zhong X, Emami A, Safa AR: Taxol induces caspase-10-dependent apoptosis. J Biol Chem 279:51057\u201351067, 20041545211710.1074\/jbc.M406543200"},{"key":"b30-jns161197","series-title":"Brain Res","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.brainres.2010.04.036","article-title":"Sulforaphane protects brains against hypoxic-ischemic injury through induction of Nrf2-dependent phase 2 enzyme","volume":"1343","author":"Ping Z,","year":"2010","unstructured":"Ping Z, Liu W, Kang Z, Cai J, Wang Q, Cheng N, : Sulforaphane protects brains against hypoxic-ischemic injury through induction of Nrf2-dependent phase 2 enzyme. Brain Res 1343:178\u2013185, 20102041762610.1016\/j.brainres.2010.04.036"},{"key":"b31-jns161197","series-title":"Epigenetics","doi-asserted-by":"publisher","first-page":"612","DOI":"10.4161\/epi.24710","article-title":"HDAC turnover, CtIP acetylation and dysregulated DNA damage signaling in colon cancer cells treated with sulforaphane and related dietary isothiocyanates","volume":"8","author":"Rajendran P,","year":"2013","unstructured":"Rajendran P, Kidane AI, Yu TW, Dashwood WM, Bisson WH, L\u00f6hr CV, : HDAC turnover, CtIP acetylation and dysregulated DNA damage signaling in colon cancer cells treated with sulforaphane and related dietary isothiocyanates. Epigenetics 8:612\u2013623, 20132377068410.4161\/epi.24710"},{"key":"b32-jns161197","series-title":"J Biomed Res","first-page":"30","article-title":"Emerging targets for glioblastoma stem cell therapy","volume":"30","author":"Safa AR,","year":"2015","unstructured":"Safa AR, Saadatzadeh MR, Cohen-Gadol AA, Pollok KE, Bijangi-Vishehsaraei K: Emerging targets for glioblastoma stem cell therapy. J Biomed Res 30:30, 2015"},{"key":"b33-jns161197","series-title":"Genes Dis","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.gendis.2015.02.001","article-title":"Glioblastoma stem cells (GSCs) epigenetic plasticity and interconversion between differentiated non-GSCs and GSCs","volume":"2","author":"Safa AR,","year":"2015","unstructured":"Safa AR, Saadatzadeh MR, Cohen-Gadol AA, Pollok KE, Bijangi-Vishehsaraei K: Glioblastoma stem cells (GSCs) epigenetic plasticity and interconversion between differentiated non-GSCs and GSCs. Genes Dis 2:152\u2013163, 20152613750010.1016\/j.gendis.2015.02.001"},{"key":"b34-jns161197","series-title":"Clin Cancer Res","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1158\/1078-0432.CCR-05-2510","article-title":"Use of an orthotopic xenograft model for assessing the effect of epidermal growth factor receptor amplification on glioblastoma radiation response","volume":"12","author":"Sarkaria JN,","year":"2006","unstructured":"Sarkaria JN, Carlson BL, Schroeder MA, Grogan P, Brown PD, Giannini C, : Use of an orthotopic xenograft model for assessing the effect of epidermal growth factor receptor amplification on glioblastoma radiation response. Clin Cancer Res 12:2264\u20132271, 20061660904310.1158\/1078-0432.CCR-05-2510"},{"key":"b35-jns161197","series-title":"BioMed Res Int","doi-asserted-by":"publisher","first-page":"725921","DOI":"10.1155\/2014\/725921","article-title":"Stem cell niches in glioblastoma: a neuropathological view","volume":"2014","author":"Schiffer D,","year":"2014","unstructured":"Schiffer D, Mellai M, Annovazzi L, Caldera V, Piazzi A, Denysenko T, : Stem cell niches in glioblastoma: a neuropathological view. BioMed Res Int 2014:725921, 20142483443310.1155\/2014\/725921"},{"key":"b36-jns161197","series-title":"Biochem Biophys Res Commun","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.bbrc.2008.09.150","article-title":"Sulforaphane induces DNA double strand breaks predominantly repaired by homologous recombination pathway in human cancer cells","volume":"377","author":"Sekine-Suzuki E,","year":"2008","unstructured":"Sekine-Suzuki E, Yu D, Kubota N, Okayasu R, Anzai K: Sulforaphane induces DNA double strand breaks predominantly repaired by homologous recombination pathway in human cancer cells. Biochem Biophys Res Commun 377:341\u2013345, 20081885417410.1016\/j.bbrc.2008.09.150"},{"key":"b37-jns161197","series-title":"BioMed Res Int","doi-asserted-by":"publisher","first-page":"402386","DOI":"10.1155\/2015\/402386","article-title":"Cytotoxic and antitumor activity of sulforaphane: the role of reactive oxygen species","volume":"2015","author":"Sestili P,","year":"2015","unstructured":"Sestili P, Fimognari C: Cytotoxic and antitumor activity of sulforaphane: the role of reactive oxygen species. BioMed Res Int 2015:402386, 20152618575510.1155\/2015\/402386"},{"key":"b38-jns161197","series-title":"Mutat Res","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.mrfmmm.2010.05.003","article-title":"Sulforaphane induces DNA single strand breaks in cultured human cells","volume":"689","author":"Sestili P,","year":"2010","unstructured":"Sestili P, Paolillo M, Lenzi M, Colombo E, Vallorani L, Casadei L, : Sulforaphane induces DNA single strand breaks in cultured human cells. Mutat Res 689:65\u201373, 20102051025310.1016\/j.mrfmmm.2010.05.003"},{"key":"b39-jns161197","series-title":"Int J Oncol","first-page":"1129","article-title":"Sulforaphane down-regulates COX-2 expression by activating p38 and inhibiting NF-\u03baB-DNA-binding activity in human bladder T24 cells","volume":"34","author":"Shan Y,","year":"2009","unstructured":"Shan Y, Wu K, Wang W, Wang S, Lin N, Zhao R, : Sulforaphane down-regulates COX-2 expression by activating p38 and inhibiting NF-\u03baB-DNA-binding activity in human bladder T24 cells. Int J Oncol 34:1129\u20131134, 200919287971"},{"key":"b40-jns161197","series-title":"Clin Cancer Res","doi-asserted-by":"publisher","first-page":"6855","DOI":"10.1158\/1078-0432.CCR-08-0903","article-title":"Sulforaphane enhances the therapeutic potential of TRAIL in prostate cancer orthotopic model through regulation of apoptosis, metastasis, and angiogenesis","volume":"14","author":"Shankar S,","year":"2008","unstructured":"Shankar S, Ganapathy S, Srivastava RK: Sulforaphane enhances the therapeutic potential of TRAIL in prostate cancer orthotopic model through regulation of apoptosis, metastasis, and angiogenesis. Clin Cancer Res 14:6855\u20136866, 20081898098010.1158\/1078-0432.CCR-08-0903"},{"key":"b41-jns161197","series-title":"Cancer Epidemiol","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.canep.2010.09.008","article-title":"Anti-carcinogenic effects of sulforaphane in association with its apoptosis-inducing and anti-inflammatory properties in human cervical cancer cells","volume":"35","author":"Sharma C,","year":"2011","unstructured":"Sharma C, Sadrieh L, Priyani A, Ahmed M, Hassan AH, Hussain A: Anti-carcinogenic effects of sulforaphane in association with its apoptosis-inducing and anti-inflammatory properties in human cervical cancer cells. Cancer Epidemiol 35:272\u2013278, 20112095609710.1016\/j.canep.2010.09.008"},{"key":"b42-jns161197","series-title":"CA Cancer J Clin","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3322\/caac.21166","article-title":"Cancer statistics, 2013","volume":"63","author":"Siegel R,","year":"2013","unstructured":"Siegel R, Naishadham D, Jemal A: Cancer statistics, 2013. CA Cancer J Clin 63:11\u201330, 20132333508710.3322\/caac.21166"},{"key":"b43-jns161197","series-title":"Cell Death Dis","doi-asserted-by":"publisher","first-page":"e1601","DOI":"10.1038\/cddis.2014.566","article-title":"Reactive oxygen species-mediated therapeutic response and resistance in glioblastoma","volume":"6","author":"Singer E,","year":"2015","unstructured":"Singer E, Judkins J, Salomonis N, Matlaf L, Soteropoulos P, McAllister S, : Reactive oxygen species-mediated therapeutic response and resistance in glioblastoma. Cell Death Dis 6:e1601, 20152559081110.1038\/cddis.2014.566"},{"key":"b44-jns161197","series-title":"Lancet Oncol","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","article-title":"Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial","volume":"10","author":"Stupp R,","year":"2009","unstructured":"Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, : Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10:459\u2013466, 200910.1016\/S1470-2045(09)70025-7"},{"key":"b45-jns161197","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp R,","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB, : Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987\u2013996, 20051575800910.1056\/NEJMoa043330"},{"key":"b46-jns161197","series-title":"Cancer Metab","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/2049-3002-2-17","article-title":"Mitochondrial reactive oxygen species and cancer","volume":"2","author":"Sullivan LB,","year":"2014","unstructured":"Sullivan LB, Chandel NS: Mitochondrial reactive oxygen species and cancer. Cancer Metab 2:17, 20142567110710.1186\/2049-3002-2-17"},{"key":"b47-jns161197","series-title":"Antioxid Redox Signal","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1089\/ars.2014.6097","article-title":"Dietary sulforaphane in cancer chemoprevention: the role of epigenetic regulation and HDAC inhibition","volume":"22","author":"Tortorella SM,","year":"2015","unstructured":"Tortorella SM, Royce SG, Licciardi PV, Karagiannis TC: Dietary sulforaphane in cancer chemoprevention: the role of epigenetic regulation and HDAC inhibition. Antioxid Redox Signal 22:1382\u20131424, 20152536488210.1089\/ars.2014.6097"},{"key":"b48-jns161197","series-title":"Eur J Cancer","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/0959-8049(92)90432-2","article-title":"DNA damage by drugs and radiation: what is important and how is it measured?","volume":"28","author":"Whitaker SJ:","year":"1992","unstructured":"Whitaker SJ: DNA damage by drugs and radiation: what is important and how is it measured?. Eur J Cancer 28:273\u2013276, 199210.1016\/0959-8049(92)90432-2"},{"key":"b49-jns161197","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s11060-015-1980-1","article-title":"How to train glioma cells to die: molecular challenges in cell death","volume":"126","author":"Wojton J,","year":"2016","unstructured":"Wojton J, Meisen WH, Kaur B: How to train glioma cells to die: molecular challenges in cell death. J Neurooncol 126:377\u2013384, 20162654202910.1007\/s11060-015-1980-1"},{"key":"b50-jns161197","series-title":"Oncogene","doi-asserted-by":"publisher","first-page":"4486","DOI":"10.1038\/sj.onc.1208656","article-title":"Suppression of NF-\u03baB and NF-\u03baB-regulated gene expression by sulforaphane and PEITC through I\u03baB\u03b1, IKK pathway in human prostate cancer PC-3 cells","volume":"24","author":"Xu C,","year":"2005","unstructured":"Xu C, Shen G, Chen C, G\u00e9linas C, Kong AN: Suppression of NF-\u03baB and NF-\u03baB-regulated gene expression by sulforaphane and PEITC through I\u03baB\u03b1, IKK pathway in human prostate cancer PC-3 cells. Oncogene 24:4486\u20134495, 20051585602310.1038\/sj.onc.1208656"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/127\/6\/article-p1219.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/127\/6\/article-p1219.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/127\/6\/article-p1219.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T22:15:31Z","timestamp":1742681731000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/127\/6\/article-p1219.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":50,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.3171\/2016.8.jns161197","relation":{},"ISSN":["0022-3085","1933-0693"],"issn-type":[{"value":"0022-3085","type":"print"},{"value":"1933-0693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]}}}